|
|
| Research article summary (published 29 Sep 2009): |
Does hepatitis B surface antigen kinetics, including both decline and reaching a threshold, improve prediction of response?
Full Abstract
No abstract is available for this article. See 'Journal and Publication Information' further down the page for details that may assist you in locating this article in electronic or hard copy media. The 'Related articles' section also further down the page, where available, may show links to abstracts of articles covering similar topics.
Author information
Author/s: Wiegand, Johannes (J); Patel, Keyur (K); Tillmann, Hans L (HL);
Journal and publication information
Publication Type: Comment; Letter
Journal: Hepatology (Baltimore, Md.) (Hepatology), published in United States. (Language: eng)
Reference: 2009-Oct; vol 50 (issue 4) : pp 1314; author reply 1314
Dates: Created 2009/10/05; Completed 2009/10/20;
PMID: 19676132, status: MEDLINE (last retrieval date: 10/20/2009, IMS Date: )
Sourced from the National Library of Medicine. Abstract text and other information may be subject to copyright.
Comments and Corrections
CommentOn: Hepatology. 2009 Apr;49(4):1141-50. (PMID: 19338056)
CommentOn: Hepatology. 2009 Apr;49(4):1151-7. (PMID: 19115222)
External Links for this article
(including full text providers, if available):
Click Electronic Full-text Provider Links to see options for finding the electronic full text links to this article. Note there may be a subscription or fee required for access to the full text. See our FAQ for information on finding FREE full text articles.
This article may also be located in paper journal collections available in many libraries. Use the Journal and Publication Information above to find the full article.
MeSH headings (categories)
This article was linked to the MESH Headings shown below.
Related articles
These are the highest related articles currently in the database:
- Baseline HBV DNA level is the most important factor associated with virologic breakthrough in chronic hepatitis B treated with lamivudine.
12 Aug 2007 - Response to interferon-alpha in chronic hepatitis B patients with and without precore mutant strain and effects on HBsAg titers.
10 Oct 2007 - [Clinical efficacy of lamivudine in the treatment of chronic hepatitis B]
30 May 2001 - Serum HBV DNA as a marker of efficacy during therapy for chronic HBV infection: analysis and review of the literature.
30 May 2003 - Antiviral treatment of hepatitis B virus-transgenic mice by a marine organism, Styela plicata.
5 Jul 2006 - Differences of YMDD mutational patterns, precore/core promoter mutations, serum HBV DNA levels in lamivudine-resistant hepatitis B genotypes B and C.
30 Oct 2007 - Is there a meaningful serum hepatitis B virus DNA cutoff level for therapeutic decisions in hepatitis B e antigen-negative chronic hepatitis B virus infection?
30 Oct 2008 - A randomized double-blind placebo-controlled study of lamivudine in the treatment of patients with chronic hepatitis B virus infection.
29 Apr 1999 - Correlation between hepatitis B virus DNA levels and liver histology: is the controversy because of paucity of data?
30 Mar 2007 - Extended lamivudine treatment in patients with HBeAg-negative chronic hepatitis B.
30 Jan 2005
Related Article Map
Legend:
- FREE Full text Article.
- Abstract only.
- Title only. More help.
See a large map of 100+ related articles.